Art

J-GLOBAL ID：202002288583009923   Reference number：20A2521534

Clinical efficacy of mogamulizumab for relapsed/refractory aggressive adult T-cell leukemia/lymphoma: A retrospective analysis

再発/難治性侵襲性成人T細胞白血病/リンパ腫に対するモガムリズマブの臨床効果:後ろ向き解析【JST・京大機械翻訳】

Author (12)： Satake Atsushi (First Department of Internal Medicine, Kansai Medical University, Osaka, Japan) ,  Konishi Akiko (First Department of Internal Medicine, Kansai Medical University, Osaka, Japan) ,  Azuma Yoshiko (First Department of Internal Medicine, Kansai Medical University, Osaka, Japan) ,  Tsubokura Yukie (First Department of Internal Medicine, Kansai Medical University, Osaka, Japan) ,  Yoshimura Hideaki (First Department of Internal Medicine, Kansai Medical University, Osaka, Japan) ,  Hotta Masaaki (First Department of Internal Medicine, Kansai Medical University, Osaka, Japan) ,  Nakanishi Takahisa (First Department of Internal Medicine, Kansai Medical University, Osaka, Japan) ,  Fujita Shinya (First Department of Internal Medicine, Kansai Medical University, Osaka, Japan) ,  Nakaya Aya (First Department of Internal Medicine, Kansai Medical University, Osaka, Japan) ,  Ito Tomoki (First Department of Internal Medicine, Kansai Medical University, Osaka, Japan) ,  Ishii Kazuyoshi (First Department of Internal Medicine, Kansai Medical University, Osaka, Japan) ,  Nomura Shosaku (First Department of Internal Medicine, Kansai Medical University, Osaka, Japan)
Material： European Journal of Haematology  (Eur J Haematol)
Volume： 105  Issue： 6  Page： 704-711  Publication year： 2020 
JST Material Number： B0958B  ISSN： 0902-4441  Document type： Article
Article type： 原著論文  Country of issue： United States (USA)  Language： ENGLISH (EN)

Abstract/Point： OBJECTIVES: Although phase 2 s...

Register(free) or Log In to access     To see more with JDream III (charged).   {{ this.onShowAbsJLink("http://jdream3.com/lp/jglobal/index.html?docNo=20A2521534&from=J-GLOBAL&jstjournalNo=B0958B") }}

Thesaurus term： *lymphoma ,  percent conversion ,  effectiveness ,  *adult T cell leukemia ,  phase 2 study ,  one year survival rate
Semi thesaurus term： サルベージ療法 ,  1年全生存率 ,  *モガムリズマブ , 【Automatic Indexing@JST】

Author keywords (7)： adult T-cell leukemia/lymphoma ,  CC chemokine receptor 4 ,  human T-lymphotropic virus type I ,  humanized monoclonal antibody ,  mogamulizumab ,  overall survival ,  prognostic index

JST classification (2)： Blood cell tumors(=neoplasms)  (GK04000M) ,  Clinical application of antitumor(=antineoplastic)drugs  (GW16020L)

Terms in the title (7)： 再発 ,  侵襲性 ,  成人T細胞白血病 ,  リンパ腫 ,  モガムリズマブ ,  臨床効果 ,  後ろ向き解析